Enterovirus Surges Fail to Trigger Acute Flaccid Myelitis Spike, CDC Reports
CDC data reveals that recent surges in enterovirus D68 infections did not cause a rise in acute flaccid myelitis cases, easing fears of a new outbreak.
A Surprising Disconnect in Viral Patterns
Public health officials are observing a puzzling trend regarding the intersection of common respiratory viruses and a rare, polio-like neurological condition. Despite significant seasonal spikes in enterovirus D68 (EV-D68) infections—a virus historically linked to the onset of acute flaccid myelitis (AFM)—the anticipated corresponding surge in neurological cases failed to materialize during 2022, 2024, and 2025. This data, recently published by the Centers for Disease Control and Prevention (CDC), provides a moment of relief for clinicians but leaves experts searching for the underlying cause of this divergence.
Understanding the Case Numbers
The CDC reports 172 confirmed cases of AFM between January 2020 and December 2025. Annual figures fluctuated between a low of 17 in 2025 and a high of 48 in 2022. These totals remain substantially lower than previous peak periods, such as 2014, 2016, and 2018, when annual counts reached as high as 238. Adriana Lopez, MHS, of the CDC’s National Center for Immunization and Respiratory Diseases, highlighted that in 2025, only a single patient diagnosed with AFM tested positive for EV-D68 in respiratory samples.
Potential Reasons for Reduced Neurovirulence
Why does a high prevalence of EV-D68 no longer guarantee a spike in AFM? Researchers offer a compelling hypothesis: the virus itself may be evolving. Newer strains circulating in recent years appear to lack specific proteins associated with neurovirulence. Laboratory studies involving mice indicate that the dominant strains currently in circulation are less likely to invade the nervous system, potentially explaining the lower incidence of paralytic complications despite high viral transmission rates.
Clinical Vigilance Remains Paramount
While the current data is encouraging, health authorities emphasize that the medical community cannot afford to let its guard down. Clinicians are urged to remain highly alert for patients presenting with sudden limb weakness or spinal cord abnormalities. The CDC stresses the importance of rapid reporting to local health departments and the collection of stool samples to definitively rule out poliovirus. Furthermore, maintaining high polio vaccination coverage is essential, as 75% to 100% of AFM patients in the recent study group had received at least three doses of the polio vaccine.
Demographics and Patient Outcomes
AFM continues to disproportionately affect children, with those under 18 accounting for approximately 75% of all cases. The median age of patients shifted slightly, from 7 years in 2022 to 12 years in 2023. While the vast majority of patients required hospitalization, there were zero reported deaths during the 2020-2025 period. Future surveillance efforts aim to address current gaps, such as the under-collection of stool specimens, which currently falls short of the recommended 80% threshold for robust public health tracking.
Recent Developments
Public health authorities are keeping a close eye on viral trends, with the latest updates on AFM surveillance providing crucial insights for pediatricians. This breaking news highlights how evolving pathogens can change the landscape of infectious disease risks in live news scenarios. You can follow all developments instantly on NeuroBulletin.com.
Related Topics
🔹 Acute Flaccid Myelitis 🔹 Enterovirus D68 🔹 Pediatric Neurology 🔹 CDC Disease Surveillance 🔹 Public Health Policy 🔹 Viral Evolution 🔹 Vaccine Advocacy
Treatments News
This category provides breaking news and the latest updates on clinical interventions and diagnostic protocols for rare neurological conditions. We deliver live reporting on how medical treatments and public health strategies adapt to emerging infectious threats, exclusively on NeuroBulletin.com.
Frequently Asked Questions
What is the link between Enterovirus D68 and AFM?
Historically, EV-D68 has been associated with outbreaks of acute flaccid myelitis, particularly when respiratory infection spikes occur. However, recent data shows this correlation has weakened, suggesting newer strains may be less neurovirulent.
Should parents be worried about polio-like symptoms?
While AFM is a rare condition, parents should remain vigilant for sudden muscle weakness in children. Because it mimics polio, prompt medical evaluation and testing are necessary for accurate diagnosis.
Why is stool collection important for AFM patients?
Stool collection is critical for ruling out poliovirus, which is the primary public health concern for any acute flaccid paralysis case. It ensures that surveillance accurately distinguishes between AFM and other preventable diseases.
Is there a vaccine for AFM?
There is currently no specific vaccine for AFM. However, maintaining high polio vaccination rates is strongly recommended to protect against polio, which presents with similar neurological symptoms.